Traders should monitor the May 4 earnings call for updates on commercial performance of AUVELITY, SUNOSI, and SYMBRAVO, as well as R&D progress. The prior quarter's EPS beat suggests potential operating leverage, but absence of guidance limits forward insight.
Price Chart
Executive Summary
Axsome Therapeutics announced it will report Q1 2026 financial results on May 4, 2026, followed by a conference call. The filing is a routine earnings announcement with no financial results disclosed yet. A prior press release reported Q4 2025 results with EPS of -$0.56, beating estimates of -$0.76 by 25.9%.
Key Financial Metrics
Key Facts
- Company to report Q1 2026 financial results on May 4, 2026, before market open
- Conference call scheduled for 8:00 a.m. ET to discuss results and provide business update
- No financial results were included in this press release
- Q4 2025 EPS was -$0.56 (beat consensus estimate of -$0.76 by 25.9%)
- Q4 2025 revenue was $195.1M, in line with consensus
Financial Impact
No financial data disclosed in this release
Risk Factors
- Forward-looking statements subject to regulatory, commercial, and clinical trial risks
- No update on cash runway or gross-to-net sales trends in this release
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3269965 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | Institutional Cluster | $214.66 $211.12 | ▼ −1.65% | ▲ +0.25% | $176.95 (−17.57%) |
Aug 10, 2026 7w ago | 8-K | $220.89 $207.82 | ▼ −5.92% | ▼ −5.00% | $176.95 (−19.89%) |
Aug 10, 2026 7w ago | Press Release | $220.89 $207.82 | ▼ −5.92% | ▼ −5.00% | $176.95 (−19.89%) |
Jul 15, 2026 11w ago | Press Release | $237.53 $214.66 | ▼ −9.63% | ▼ −11.97% | $176.95 (−25.51%) |
Jul 9, 2026 12w ago | Court Ruling | $248.95 $210.13 | ▼ −15.59% | ▼ −17.84% | $176.95 (−28.92%) |
Jul 7, 2026 12w ago | Press Release | $249.76 $211.04 | ▼ −15.50% | ▼ −16.84% | $176.95 (−29.15%) |
Jul 1, 2026 13w ago | 144 | $244.31 $234.64 | ▼ −3.96% | ▼ −3.54% | $176.95 (−27.57%) |
Jun 15, 2026 15w ago | Press Release | $253.40 $228.28 | ▼ −9.91% | ▼ −9.16% | $176.95 (−30.17%) |
Jun 12, 2026 16w ago | Insider Cluster | $255.17 $233.80 | ▼ −8.37% | ▼ −10.15% | $176.95 (−30.66%) |
Jun 11, 2026 16w ago | 144 | $255.17 $233.80 | ▼ −8.37% | ▼ −10.15% | $176.95 (−30.66%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access